Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
3 months ago
Senator Cynthia Lummis warns of a potential four-year delay for the CLARITY Act if action isn't taken before the 2026 midterms. With regulatory uncertainty looming, crypto firms may look overseas, leaving the U.S. behind in the digital race.
3 months ago
Pfizer's attractive 6.4% dividend yield amid its recent financial struggles. As the pharmaceutical giant grapples with revenue dips post-pandemic, can it sustain this payout? Let's analyze the potential outcomes and implications for investors.
3 months ago
The CLARITY Act faces a critical deadline. If not passed by 2026, regulatory uncertainties may push crypto innovation overseas. Can the Senate beat the clock?